L. Kyne, M. B. Hamel, R. Polavaram, and C. P. Kelly, Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile, Clin Infect Dis. 1 févr, vol.34, issue.3, pp.346-53, 2002.

D. A. Leffler and J. T. Lamont, Clostridium difficile Infection, New England Journal of Medicine. 16 avr, vol.372, issue.16, pp.1539-1587, 2015.

. Ss, M. D. Magill, .. D. Ph, J. R. Edwards, M. Stat et al., Multistate Point-Prevalence Survey of Health Care-Associated Infections | NEJM

D. Sur,

K. R. Reveles, G. C. Lee, N. K. Boyd, and C. R. Frei, The rise in Clostridium difficile infection incidence among hospitalized adults in the United States, American Journal of Infection Control, vol.42, issue.10, pp.1028-1060, 2001.

F. C. Lessa, Y. Mu, W. M. Bamberg, Z. G. Beldavs, G. K. Dumyati et al., Burden of Clostridium difficile Infection in the United States

D. Sur,

. Arid%3acrossref,

M. P. Bauer, D. W. Notermans, B. H. Van-benthem, J. S. Brazier, M. H. Wilcox et al., Clostridium difficile infection in Europe: a hospitalbased survey. The Lancet, janv, vol.377, issue.9759, pp.63-73, 2011.

K. A. Davies, H. Ashwin, C. M. Longshaw, D. A. Burns, G. L. Davis et al., Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, pointprevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), Eurosurveillance. 21 juill, vol.21, issue.29, p.30294, 2012.

A. Cassini, D. Plachouras, T. Eckmanns, M. A. Sin, H. Blank et al., Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study, PLOS Medicine, vol.13, issue.10, p.1002150, 2016.

E. J. Kuijper, B. Coignard, and P. Tüll, Emergence of Clostridium difficileassociated disease in North America and Europe, Clinical Microbiology and Infection, vol.12, pp.2-18, 2006.

S. Khanna, D. S. Pardi, S. L. Aronson, P. P. Kammer, R. Orenstein et al., The Epidemiology of Community-acquired Clostridium difficile infection: A population-based study, Am J Gastroenterol. janv, vol.107, issue.1, pp.89-95, 2012.

C. S. Thornton, J. E. Rubin, A. L. Greninger, G. Peirano, C. Y. Chiu et al., Epidemiological and genomic characterization of communityacquired Clostridium difficile infections, BMC Infect Dis, vol.31, 2018.

M. Ogielska, P. Lanotte, L. Brun, C. Valentin, A. S. Garot et al., Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature, International Journal of Infectious Diseases. août, vol.37, pp.36-41, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01183893

A. Gupta and S. Khanna, Community-acquired Clostridium difficile infection: an increasing public health threat, Infect Drug Resist. 17 mars, vol.7, pp.63-72, 2014.

L. E. Bloomfield and T. V. Riley, Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review, Infect Dis Ther. sept, vol.5, issue.3, pp.231-51, 2016.

J. Freeman, M. P. Bauer, S. D. Baines, J. Corver, W. N. Fawley et al., The Changing Epidemiology of Clostridium difficile Infections, Clin Microbiol Rev. juill, vol.23, issue.3, pp.529-578, 2010.

. Dorp-sm-van, P. Kinross, P. Gastmeier, M. Behnke, A. Kola et al., Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, Eurosurveillance. 21 juill, vol.21, issue.29, p.30293, 2013.

N. Cassir, N. Fahsi, G. Durand, J. Lagier, D. Raoult et al., Emergence of Clostridium difficile tcdC variant 078 in, vol.36, pp.1971-1975, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01730442

W. N. Fawley, K. A. Davies, T. Morris, P. Parnell, R. Howe et al., Enhanced surveillance of Clostridium difficile infection occurring outside hospital, Eurosurveillance. 21 juill, vol.21, issue.29, p.30295, 2011.

J. H. Boone, M. Goodykoontz, S. J. Rhodes, K. Price, J. Smith et al., Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and 23 specimen consistency, European Journal of Clinical Microbiology & Infectious Diseases. juill, vol.31, issue.7, pp.1551-1560, 2012.

S. B. Debast, M. P. Bauer, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection, Clinical Microbiology and Infection. mars, vol.20, pp.1-26, 2014.

A. Pechal, K. Lin, S. Allen, and K. Reveles, National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals, BMC Infect Dis, vol.16, issue.17, 2016.

M. D. Esteban-vassallo, S. Pellicer, M. F. Dominguez-berjon, C. Caballero, M. Asensio et al., Age and gender differences in Clostridium difficile-related hospitalization trends in Madrid (Spain) over a 12-year period, Eur J Clin Microbiol Infect Dis. juin, vol.35, issue.6, pp.1037-1044, 2016.

F. Barbut, P. Mastrantonio, M. Delmée, J. Brazier, E. Kuijper et al., Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates, Clinical Microbiology and Infection, vol.13, issue.11, pp.1048-57, 2007.

G. Dumyati, V. Stevens, G. E. Hannett, A. D. Thompson, C. Long et al., Community-associated Clostridium difficile Infections, Emerg Infect Dis. mars, vol.18, issue.3, pp.392-400, 2012.

A. S. Chitnis, S. M. Holzbauer, R. M. Belflower, L. G. Winston, W. M. Bamberg et al., Epidemiology of Community-Associated Clostridium difficile Infection, JAMA Intern Med. 22 juill, vol.173, issue.14, pp.1359-67, 2009.

J. F. Rodemann, E. R. Dubberke, K. A. Reske, D. H. Seo, and C. D. Stone, Incidence of Clostridium difficile Infection in Inflammatory Bowel Disease -Clinical Gastroenterology and Hepatology

P. Bossuyt, J. Verhaegen, G. Van-assche, P. Rutgeerts, and S. Vermeire, Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease, Journal of Crohn's and Colitis. févr, vol.3, issue.1, pp.4-7, 2009.

J. D'aoust, R. Battat, and T. Bessissow, Management of inflammatory bowel disease with Clostridium difficile infection, World J Gastroenterol. 21 juill, vol.23, issue.27, pp.4986-5003, 2017.

S. ;. Hourigan, M. Oliva-hemker, and S. Hutfless, The Prevalence of Clostridium difficile Infection in Pediatric and Adult Patients with Inflammatory Bowel Disease, Dig Dis Sci. Sep2014, vol.9, pp.2222-2227

A. Ramos-martínez, J. Ortiz-balbuena, I. Curto-garcía, Á. Asensio-vegas, R. Martínez-ruiz et al., Risk factors for Clostridium difficile diarrhea in patients with inflammatory bowel disease, Rev Esp Enferm Dig, vol.107, p.5, 2015.

W. Gillespie, N. Marya, J. Fahed, G. Leslie, K. Patel et al., Clostridium difficile in Inflammatory Bowel Disease: A Retrospective Study, Gastroenterol Res Pract, 2017.

B. Balram, R. Battatb, A. Al-khourya, J. D. Aoust, W. Afifb et al., Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, Journal of Crohn's and Colitis. 21 sept, vol.2018, pp.1-12, 2018.

M. H. Wilcox, L. Mooney, R. Bendall, C. D. Settle, and W. N. Fawley, A casecontrol study of community-associated Clostridium difficile infection, J Antimicrob Chemother. 1 août, vol.62, issue.2, pp.388-96, 2008.

C. Rousseau, L. Lemee, L. Monnier, A. Poilane, I. Pons et al., Prevalence and diversity of Clostridium difficile strains in infants, Journal of Medical Microbiology. 1 août, vol.60, issue.8, pp.1112-1120, 2011.

C. Rousseau, I. Poilane, D. Pontual, L. Maherault, A. et al., Clostridium difficile Carriage in Healthy Infants in the Community: A Potential Reservoir for Pathogenic Strains, Clinical Infectious Diseases, vol.55, issue.9, pp.1209-1224, 2012.

K. Nissle, D. Kopf, and A. Rösler, Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients, BMC Geriatr, vol.16, issue.15, 2016.

F. Miyajima, P. Roberts, A. Swale, V. Price, M. Jones et al., Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom, Disponible sur, vol.23

H. Kato, H. Kita, T. Karasawa, T. Maegawa, Y. Koino et al., Colonisation and transmission of Clostridium diffcile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis, 2019.

J. A. Unger, E. Whimbey, M. G. Gravett, and D. A. Eschenbach, The Emergence of Clostridium difficile Infection among Peripartum Women: A Case-Control Study of a C. difficile Outbreak on an Obstetrical Service, Infect Dis Obstet Gynecol, 2011.

K. W. Garey, Z. Jiang, Y. Yadav, B. Mullins, K. Wong et al., Peripartum Clostridium difficile infection: case series and review of the literature, American Journal of Obstetrics & Gynecology, vol.199, issue.4, pp.332-339, 2008.

C. Verdot, Corpulence des enfants et des adultes en france métropolitaine en 2015. résultats de l'étude esteban et évolution depuis 2006 / children and adults body mass index in france in 2015. results of the esteban study and trends

J. Leung, B. Burke, D. Ford, G. Garvin, C. Korn et al., Possible Association between Obesity and Clostridium difficile Infection. Emerg Infect Dis, vol.19, pp.1791-1797, 2013.

J. Bishara, R. Farah, J. Mograbi, W. Khalaila, O. Abu-elheja et al., Obesity as a Risk Factor for Clostridium difficile Infection, Clin Infect Dis. 15 août, vol.57, issue.4, pp.489-93, 2013.

A. Pasquereau, La consommation de tabac en france : premiers résultats du baromètre santé 2017 / Tobacco consumption in france, p.9

M. Rogers, M. T. Greene, S. Saint, C. E. Chenoweth, P. N. Malani et al., Higher Rates of Clostridium difficile Infection among Smokers, PLoS One [Internet]. 27 juill 2012, vol.7

A. K. Barker, A. Van-galen, A. K. Sethi, D. Shirley, and N. Safdar, Tobacco use as a screener for Clostridium difficile infection outcomes, J Hosp Infect. janv, vol.98, issue.1, pp.36-45, 2018.

S. Dial, J. Delaney, .. C. Barkun, A. N. Suissa, and S. , Use of Gastric Acid-Suppressive Agents and the Risk of Community-Acquired Clostridium difficile-Associated Disease, JAMA. 21 déc, vol.294, issue.23, pp.2989-95, 2005.

V. Arriola, J. Tischendorf, J. Musuuza, A. Barker, J. W. Rozelle et al., Assessing the risk of hospital-acquired clostridium difficile infection with proton pump inhibitor use: a meta-analysis, Infect Control Hosp Epidemiol. déc, vol.37, issue.12, pp.1408-1425, 2016.

A. Deshpande, V. Pasupuleti, P. Thota, C. Pant, D. Rolston et al., Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis, Infection Control & Hospital Epidemiology. avr, vol.36, issue.4, pp.452-60, 2015.

J. Leonard, M. D. John, K. Marshall, M. D. , P. Moayyedi et al., Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression. Am Coll of Gastroenterology, 2007.

M. Rogers, M. T. Greene, V. B. Young, S. Saint, K. M. Langa et al., Depression, antidepressant medications, and risk of Clostridium difficile infection, BMC Med. 7 mai, vol.11, p.121, 2013.

H. Id, Utilisation de médicaments antidépresseurs et risque cardiométabolique: Analyse des données des cohortes françaises, p.237

. Gbd_2017_booklet,

D. Sur,

A. Goorhuis, D. Bakker, J. Corver, S. B. Debast, C. Harmanus et al., Emergence of Clostridium difficile Infection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078, Clin Infect Dis, vol.47, issue.9, pp.1162-70, 2008.